RansomLook: rhysida - MPA Pharma

Evidenza della rivendicazione

Evidenza acquisita dal collector isolato. La rivendicazione richiede verifica indipendente e non prova da sola una compromissione.

Descrizione pubblicata dalla fonte

MPA Pharma GmbH is an internationally active, rapidly growing company specializing in the import and trade of high-quality pharmaceuticals, including both patented and generic products. 2,899,290 files, ~5.8 TB Pharmaceutical company Categories: accounting records and database backups, government audits (customs / corporate tax / social security / wage tax), corporate ownership (nominee structure, beneficial-ownership filings, related-party payments), narcotics/BtM records (opioids, cannabis, precursors), litigation files, executive and employee personal data, IT artifacts, pharmacovigilance correspondence. Credit cards with CVV of executives, Oltersdorf ID card valid until 2030, the Pfeiffer letter on the hidden Paranova Pack B.V., UBO passports SQL backups (17.7 million general-ledger rows), commercial register extract (HRB), organizational chart Credentials (TIER 1) - a list of all password files (values not repeated here, stored in the MPA PASSWORDS report) Government audits - customs 17,011.77 EUR with a breakdown, corporate tax +202,203.18 EUR, social security (DRV) 23,134.96 EUR with a separate case against the managing director, wage-tax audit Narcotics (BtM) - permits (318 04 74), reconciliations of 588 rows / 93 differences, fentanyl, hydromorphone, oxycodone, tapentadol, unexplained remainders of 1-13 units, documentation gap 2017-2020, cannabis up to 22 percent THC, precursors Litigation - MSD/Merck memo, settlement agreement, Amgros judgment 5,180,043.09 DKK, complaint to the Ministry of Health, arbitration filing People, security, pharmacovigilance, bulk

Evidenza acquisita il

2026-09-26T00:09:20.403093+00:00

Direct access

No

Questa immagine documenta la pagina alla data di acquisizione; non certifica il suo contenuto alla data della segnalazione storica.